| Name | Title | Contact Details |
|---|---|---|
Jeremiah Barth |
Chief Financial Officer | Profile |
Andrew Wiltz |
VP of Finance | Profile |
Community Hospital Corporation owns, manages and consults with hospitals through three distinct organizations — CHC Hospitals, CHC Consulting and CHC ContinueCARE, which share a common purpose to guide, support and enhance the mission of community hospitals and healthcare providers.
Wellbeats gives people of every age, interest, body type, & ability level the same opportunity to live a healthier life.
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Milliman Care Guidelines is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our seasoned hosts will help you find the experience you’re looking for. We’re here to lend a steady hand as you navigate the wondrous world of cannabis.